Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYNJ2 intronic transcript 1 (SYNJ2-IT1) is a long non-coding RNA (lncRNA) transcribed from an intronic region (mostly described as intron 7) of the Synaptojanin 2 (SYNJ2) gene[2][5]. It does not encode a functional protein, and is distinct from the protein-coding SYNJ2 isoforms. In mice, variants of this non-coding transcript show developmental stage-specific and somatic versus gametic expression during spermatogenesis, potentially contributing to the fine regulation of SYNJ2 or neighboring genes[2][5]. There are no direct reports of SYNJ2-IT1 serving as a receptor, enzyme, transporter, or therapeutic target, nor is there evidence linking it to disease roles or therapeutic interventions. Its primary classification is as a lncRNA that may possess regulatory or structural RNA functions within the testis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SYNJ2 intronic transcript 1 (non-protein coding) (SYNJ2-IT1).